Oxford, United Kingdom

Anna Goodman

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Oxfordshire, GB (2015)
  • Oxford, GB (2018)

Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anna Goodman: Innovator in Adenoviral Vector Technology

Introduction

Anna Goodman is a prominent inventor based in Oxford, GB. She has made significant contributions to the field of biomedical research, particularly in the development of adenoviral vectors. With a total of 2 patents, her work has the potential to impact therapeutic approaches for various diseases.

Latest Patents

Anna Goodman's latest patents focus on adenoviral vectors. One of her notable inventions is an adenoviral vector that comprises a promoter further including a fragment of the 5' untranslated region of the CMV IE1 gene, along with a nucleic acid sequence encoding a pathogen or tumor antigen for use as a medicament. This innovative approach aims to enhance the efficacy of gene delivery systems in medical applications.

Career Highlights

Throughout her career, Anna has worked with esteemed organizations such as Isis Innovation Limited and Oxford University Innovation Limited. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Anna Goodman has collaborated with notable colleagues, including Simon Draper and Arturo Reyes. These partnerships have fostered a dynamic exchange of ideas and expertise, further advancing her research endeavors.

Conclusion

Anna Goodman's contributions to adenoviral vector technology exemplify her dedication to innovation in the biomedical field. Her patents and collaborations reflect her commitment to improving therapeutic strategies for various health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…